GlassScriptPhysician profile
Christopher J Diblasio
NPI 1952524274
$76,018.63
in general payments reported to CMS, 2019-2025
40 companies · $5,650 in 2025
The $5,650 reported for 2025 was more than what 91% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,714 · 2020: $1,435 · 2021: $370 · 2022: $3,493 · 2023: $5,547 · 2024: $53K · 2025: $5,650.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $55K · Travel and Lodging: $5,262 · Food and Beverage: $3,784 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $54,925.00 |
| Travel and Lodging | $5,262.48 |
| Food and Beverage | $3,784.09 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $67,605.11 | 2019-2025 | Lumenis Pulse 120h, Xpeeda Dsl Fiber, Moses 550 Dfl |
| Teleflex LLC | $2,388.20 | 2021-2025 | Urolift |
| Profound Medical Corp. | $1,078.66 | 2024 | Tulsa-Pro |
| Valencia Technologies Corporation | $705.63 | 2023-2024 | Ecoin Device Kit |
| Janssen Biotech, INC. | $507.90 | 2021-2025 | Erleada, Akeega |
| Dendreon Pharmaceuticals LLC | $438.22 | 2022-2024 | Provenge |
| Palette Life Sciences, INC. | $253.44 | 2022 | |
| Axonics, INC. | $243.04 | 2022-2024 | Axonics, Bulkamid |
| Bioprotect Medical, INC. | $223.70 | 2025 | Bioprotect Balloon Implant System |
| Varian Medical Systems, INC. | $197.43 | 2019 | |
| Myriad Genetic Laboratories, INC. | $195.68 | 2022-2024 | Prolaris |
| Procept Biorobotics Corporation | $191.49 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $163.83 | 2022-2023 | |
| Neotract INC. | $149.89 | 2020 | |
| Progenics Pharmaceuticals, INC. | $145.13 | 2023-2024 | Pylarify |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Healthtronics Stone Solutions, LLC | $144.60 | 2019 | |
| Angiodynamics, INC. | $133.30 | 2022-2024 | Nanoknife |
| Abbvie INC. | $132.13 | 2022-2025 | Botox |
| Sumitomo Pharma America, INC. | $128.82 | 2023-2025 | Orgovyx, Gemtesa |
| Laborie Medical Technologies Corp. | $126.48 | 2021-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Astellas Pharma US INC | $112.33 | 2022 | |
| Endo Pharmaceuticals INC. | $96.43 | 2022-2023 | Edex, Xiaflex, Aveed |
| Janssen Scientific Affairs, LLC | $93.95 | 2025 | Akeega, Balversa, Erleada |
| Allergan, INC. | $81.50 | 2020-2022 | |
| Olympus America INC. | $56.10 | 2024 | Itind System |
| Blue Earth Diagnostics | $54.46 | 2022-2024 | |
| Urovant Sciences INC | $51.63 | 2022 | |
| Civco Medical Instruments | $47.78 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Immunitybio, INC. | $31.10 | 2024 | |
| Tolmar, INC. | $25.07 | 2024 | |
| Coloplast Corp | $24.95 | 2025 | |
| Telix Pharmaceuticals | $23.36 | 2022 | |
| Novartis Pharmaceuticals Corporation | $23.09 | 2022 | |
| Urogen Pharma, INC. | $22.20 | 2022 | |
| Merck Sharp & Dohme LLC | $22.03 | 2024 | Keytruda |
| Pacira Pharmaceuticals Incorporated | $21.00 | 2022 | |
| Femselect INC. | $16.03 | 2024 | Enplace |
| Ferring Pharmaceuticals INC. | $13.94 | 2024 | Adstiladrin |
| Endo USA, INC. | $13.94 | 2024 | Xiaflex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Diblasio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.